EcoDrugPlus

Tryptophan Hydroxylase 1

Ensembl ID : ENSMMNG00015021621
Gene Symbol: TPH1
1 Cross references
255 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSMMNG00015000149
Gene Symbol: TUBA1A
1 Cross references
139 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSMMNG00015021671
Gene Symbol: TUBA1B
3 Cross references
90 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMMNG00015005098
Gene Symbol: TUBA4A
1 Cross references
224 Possible Orthologues:

Tubulin Alpha-3 Chain

Ensembl ID : ENSMMNG00015003704
Gene Symbol: LOC114897631
2 Cross references
133 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSMMNG00015004239
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSMMNG00015010464
Gene Symbol: TUBB2B
3 Cross references
279 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSMMNG00015018045
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMMNG00015016340
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSMMNG00015020624
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSMMNG00015001161
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSMMNG00015000533
Gene Symbol: TUBB
3 Cross references
23 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).